Literature DB >> 22079431

Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Olivia J Holland1, Caitlin Linscheid, Herbert C Hodes, Traci L Nauser, Melissa Gilliam, Peter Stone, Larry W Chamley, Margaret G Petroff.   

Abstract

The fetal semi-allograft can induce expansion and tolerance of antigen-specific maternal T and B cells through paternally inherited major histocompatibility complex and minor histocompatibility antigens (mHAgs). The effects of these antigens have important consequences on the maternal immune system both during and long after pregnancy. Herein, we investigate the possibility that the placental syncytiotrophoblast and deported trophoblastic debris serve as sources of fetal mHAgs. We mapped the expression of four mHAgs (human mHAg 1, pumilio domain-containing protein KIAA0020, B-cell lymphoma 2-related protein A1, and ribosomal protein S4, Y linked) in the placenta. Each of these proteins was expressed in several placental cell types, including the syncytiotrophoblast. These antigens and two additional Y chromosome-encoded antigens [DEAD box polypeptide 3, Y linked (DDX3Y), and lysine demethylase5D] were also identified by RT-PCR in the placenta, purified trophoblast cells, and cord blood cells. Finally, we used a proteomic approach to investigate the presence of mHAgs in the syncytiotrophoblast and trophoblast debris shed from first-trimester placenta. By this method, four antigens (DDX3Y; ribosomal protein S4, Y linked; solute carrier 1A5; and signal sequence receptor 1) were found in the syncytiotrophoblast, and one antigen (DDX3Y) was found in shed trophoblast debris. The finding of mHAgs in the placenta and in trophoblast debris provides the first direct evidence that fetal antigens are present in debris shed from the human placenta. The data, thus, suggest a mechanism by which the maternal immune system is exposed to fetal alloantigens, possibly explaining the relationship between parity and graft-versus-host disease.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079431      PMCID: PMC3338347          DOI: 10.1016/j.ajpath.2011.09.021

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  78 in total

1.  Alloimmunity to human H-Y.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Lancet       Date:  1976-11-27       Impact factor: 79.321

2.  H-Y male antigen: detection on eight-cell mouse embryos.

Authors:  C J Krco; E H Goldberg
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

3.  Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy.

Authors:  Rob M Verdijk; Antoinette Kloosterman; Jos Pool; Maarten van de Keur; Albert M I H Naipal; Astrid G S van Halteren; Anneke Brand; Tuna Mutis; Els Goulmy
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

4.  Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response.

Authors:  A Takami; C Sugimori; X Feng; A Yachie; Y Kondo; R Nishimura; K Kuzushima; T Kotani; H Asakura; S Shiobara; S Nakao
Journal:  Bone Marrow Transplant       Date:  2004-10       Impact factor: 5.483

5.  Male DNA in female donor apheresis and CD34-enriched products.

Authors:  Kristina M Adams; Nathalie C Lambert; Shelly Heimfeld; Tracy S Tylee; Jennifer M Pang; Timothy D Erickson; J Lee Nelson
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

6.  Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.

Authors:  Kristina M Adams; Leona A Holmberg; Wendy Leisenring; Alexander Fefer; Katherine A Guthrie; Tracy S Tylee; George B McDonald; William I Bensinger; J Lee Nelson
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

7.  Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.

Authors:  H H B Sawaya; S A Jimenez; C M Artlett
Journal:  Rheumatology (Oxford)       Date:  2004-06-15       Impact factor: 7.580

8.  Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Authors:  Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

9.  Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.

Authors:  Eric Spierings; Corine J Vermeulen; Mario H Vogt; Lucie E E Doerner; J H Frederik Falkenburg; Tuna Mutis; Els Goulmy
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

10.  Regulatory T cells mediate maternal tolerance to the fetus.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

View more
  29 in total

1.  Correlative research of the incidence of preeclampsia and sperm exposure.

Authors:  Dibing Zhu; Yang Song; Qingqing Ding; Cuicui Duan; Wei Wu; Jian Xu
Journal:  Arch Gynecol Obstet       Date:  2021-05-23       Impact factor: 2.344

Review 2.  CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.

Authors:  Tamara Tilburgs; Jack L Strominger
Journal:  Am J Reprod Immunol       Date:  2013-02-23       Impact factor: 3.886

Review 3.  Placental extracellular vesicles and feto-maternal communication.

Authors:  M Tong; L W Chamley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 4.  Mechanisms of T cell tolerance towards the allogeneic fetus.

Authors:  Adrian Erlebacher
Journal:  Nat Rev Immunol       Date:  2012-12-14       Impact factor: 53.106

5.  Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity.

Authors:  Anita van der Zwan; Kevin Bi; Errol R Norwitz; Ângela C Crespo; Frans H J Claas; Jack L Strominger; Tamara Tilburgs
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-19       Impact factor: 11.205

6.  Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women.

Authors:  C Linscheid; E Heitmann; P Singh; E Wickstrom; L Qiu; H Hodes; T Nauser; M G Petroff
Journal:  Placenta       Date:  2015-06-06       Impact factor: 3.481

7.  Immune response to a model shared placenta/tumor-associated antigen reduces cancer risk in parous mice.

Authors:  Susmita Jasti; Mina Farahbakhsh; Sean Nguyen; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 8.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

Review 9.  Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy.

Authors:  Caitlin Linscheid; Margaret G Petroff
Journal:  Am J Reprod Immunol       Date:  2013-02-08       Impact factor: 3.886

10.  Complex chimerism: pregnancy after solid organ transplantation.

Authors:  Kimberly K Ma; Margaret G Petroff; Lisa A Coscia; Vincent T Armenti; Kristina M Adams Waldorf
Journal:  Chimerism       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.